Cite
HARVARD Citation
Dvorak, C. et al. (n.d.). A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency. Pediatric transplantation. pp. 609-616. [Online].